PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,129,000 | +28.3% | 303,391 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $880,000 | -49.6% | 303,391 | -54.3% | 0.00% | 0.0% |
| Q3 2018 | $1,746,000 | +111.6% | 664,220 | +88.4% | 0.00% | 0.0% |
| Q2 2018 | $825,000 | -25.9% | 352,619 | -7.0% | 0.00% | 0.0% |
| Q1 2018 | $1,114,000 | -12.8% | 378,995 | -18.7% | 0.00% | 0.0% |
| Q4 2017 | $1,277,000 | -45.5% | 466,195 | -32.5% | 0.00% | -50.0% |
| Q3 2017 | $2,342,000 | +114.1% | 690,721 | +55.9% | 0.00% | +100.0% |
| Q2 2017 | $1,094,000 | +7.5% | 443,001 | -1.2% | 0.00% | 0.0% |
| Q1 2017 | $1,018,000 | -0.7% | 448,514 | -7.2% | 0.00% | 0.0% |
| Q4 2016 | $1,025,000 | -45.7% | 483,359 | -14.3% | 0.00% | 0.0% |
| Q3 2016 | $1,889,000 | -10.1% | 563,870 | -15.7% | 0.00% | -50.0% |
| Q2 2016 | $2,101,000 | +18.0% | 668,990 | +25.1% | 0.00% | +100.0% |
| Q1 2016 | $1,781,000 | -4.6% | 534,775 | +1.4% | 0.00% | 0.0% |
| Q4 2015 | $1,866,000 | -30.5% | 527,216 | -1.2% | 0.00% | -50.0% |
| Q3 2015 | $2,684,000 | -24.2% | 533,694 | -3.1% | 0.00% | -33.3% |
| Q2 2015 | $3,542,000 | -7.2% | 550,904 | +1.5% | 0.00% | 0.0% |
| Q1 2015 | $3,818,000 | -11.3% | 542,748 | -2.8% | 0.00% | 0.0% |
| Q4 2014 | $4,306,000 | -2.3% | 558,475 | -5.3% | 0.00% | 0.0% |
| Q3 2014 | $4,407,000 | -24.0% | 589,910 | -1.6% | 0.00% | -25.0% |
| Q2 2014 | $5,800,000 | -14.8% | 599,215 | -26.9% | 0.00% | -20.0% |
| Q1 2014 | $6,808,000 | -12.1% | 819,266 | -10.7% | 0.01% | -16.7% |
| Q4 2013 | $7,745,000 | +10.9% | 917,702 | +4.7% | 0.01% | +20.0% |
| Q3 2013 | $6,983,000 | +1.9% | 876,122 | -1.3% | 0.01% | -16.7% |
| Q2 2013 | $6,853,000 | – | 887,753 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |